Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Turco

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989
Microbial glycolipids: possible virulence factors that scavenge oxygen radicalsJ Chan, T Fujiwara, P Brennan, et al.
Hospital Pharmacy|October 7, 1986
Hospital pharmacy symposium on new concepts in parenteral drug deliveryR W Anderson, J E Cohen, M R Cohen, et al.
Biochemistry|September 22, 1987
Structure of the major carbohydrate fragment of the Leishmania donovani lipophosphoglycanS J Turco, S R Hull, P A Orlandi, et al.
East African Medical Journal|October 31, 2001
Transmission blocking vaccine studies in leishmaniasis: I. Lipophosphoglycan is a promising transmission blocking vaccine molecule against cutaneous leishmaniasisW K Tonui, P A Mbati, C O Anjili, et al.
East African Medical Journal|October 31, 2001
Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c miceW K Tonui, P A Mbati, C O Anjili, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 10, 1996
Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1 beta gene expression in human monocytes via a unique promoter sequenceD E Hatzigeorgiou, J Geng, B Zhu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996
Structure-function analysis of Leishmania lipophosphoglycan. Distinct domains that mediate binding and inhibition of endothelial cell functionJ L Ho, H K Kim, P M Sass, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 1994
Evidence that the vectorial competence of phlebotomine sand flies for different species of Leishmania is controlled by structural polymorphisms in the surface lipophosphoglycanP F Pimenta, E M Saraiva, E Rowton, et al.
The Journal of Biological Chemistry|April 5, 1992
Refined structure of the lipophosphoglycan of Leishmania donovaniJ R Thomas, M J McConville, J E Thomas-Oates, et al.
Nursing Economic$|July 1, 1994
A multicenter study of costs and nursing impact of cartridge-needle unitsJ Llewellyn, R Giese, L J Nosek, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989
Microbial glycolipids: possible virulence factors that scavenge oxygen radicalsJ Chan, T Fujiwara, P Brennan, et al.
Hospital Pharmacy|October 7, 1986
Hospital pharmacy symposium on new concepts in parenteral drug deliveryR W Anderson, J E Cohen, M R Cohen, et al.
Biochemistry|September 22, 1987
Structure of the major carbohydrate fragment of the Leishmania donovani lipophosphoglycanS J Turco, S R Hull, P A Orlandi, et al.
East African Medical Journal|October 31, 2001
Transmission blocking vaccine studies in leishmaniasis: I. Lipophosphoglycan is a promising transmission blocking vaccine molecule against cutaneous leishmaniasisW K Tonui, P A Mbati, C O Anjili, et al.
East African Medical Journal|October 31, 2001
Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c miceW K Tonui, P A Mbati, C O Anjili, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 10, 1996
Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1 beta gene expression in human monocytes via a unique promoter sequenceD E Hatzigeorgiou, J Geng, B Zhu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996
Structure-function analysis of Leishmania lipophosphoglycan. Distinct domains that mediate binding and inhibition of endothelial cell functionJ L Ho, H K Kim, P M Sass, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 1994
Evidence that the vectorial competence of phlebotomine sand flies for different species of Leishmania is controlled by structural polymorphisms in the surface lipophosphoglycanP F Pimenta, E M Saraiva, E Rowton, et al.
The Journal of Biological Chemistry|April 5, 1992
Refined structure of the lipophosphoglycan of Leishmania donovaniJ R Thomas, M J McConville, J E Thomas-Oates, et al.
Nursing Economic$|July 1, 1994
A multicenter study of costs and nursing impact of cartridge-needle unitsJ Llewellyn, R Giese, L J Nosek, et al.
Pageof 15